Literature DB >> 8917024

Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit.

J S Friedland1, J C Porter, S Daryanani, J M Bland, N J Screaton, M J Vesely, G E Griffin, E D Bennett, D G Remick.   

Abstract

OBJECTIVE: To more clearly define the relationships between plasma proinflammatory cytokine concentrations, physiologic disturbance, and survival in severely ill patients.
DESIGN: Prospective, longitudinal, cohort analytic study.
SETTING: Teaching hospital intensive care unit (ICU). PATIENTS: Two hundred fifty-one consecutive nonselected patients admitted to the ICU.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Daily Acute Physiology and Chronic Health Evaluation (APACHE) III scores were calculated from clinical and laboratory data. In concurrent blood samples, plasma concentrations were measured of four proinflammatory cytokines (tumor necrosis factor-[TNF] alpha, interleukin [IL]-1 beta, IL-6, and IL-8), all of which are believed to be of central importance in host proinflammatory and immune responses. Plasma TNF concentrations were increased in 42 patients, plasma IL-1 beta in 15 patients, IL-6 in 194 patients, and IL-8 in 52 patients at presentation. Although admission plasma IL-1 beta, IL-6, and IL-8 concentrations were higher in patients who died in the ICU compared with survivors (n = 33; p < .02, p < .01, p < .02, respectively), only admission plasma IL-8 concentrations were higher in patients with a fatal outcome if all in-hospital deaths were considered (n = 53; p = .05). APACHE III score was the best predictor of mortality (odds ratio 11.41; p = .003). Detection, but not the absolute level, of TNF bioactivity in plasma was a weak independent predictor of death (odds ratio 3.17; p = .02). There was no relationship between bacteremia or presence of the systemic inflammatory response syndrome and plasma cytokine concentrations. Nineteen patients were in the ICU for > or = 10 days, and of these 19 patients, 16 patients had prolonged increases of plasma cytokines. Two patients with persistently increased plasma TNF concentrations died. Otherwise, persistently increased plasma cytokine concentrations had a variable relation to daily APACHE scores and to mortality.
CONCLUSIONS: Plasma cytokine concentrations fluctuate in serious illness and have a poor correlation with derangement of whole body physiology in seriously ill patients. Only the presence of bioactive TNF in plasma was an independent predictor of mortality. Daily measurement of plasma proinflammatory cytokine concentrations is unlikely to have clinical application in the ICU setting, except possibly in specific subgroups of patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8917024     DOI: 10.1097/00003246-199611000-00003

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  19 in total

1.  Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis.

Authors:  F Arnalich; E Garcia-Palomero; J López; M Jiménez; R Madero; J Renart; J J Vázquez; C Montiel
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis.

Authors:  C A Evans; J Jellis; S P Hughes; D G Remick; J S Friedland
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

3.  Role of interleukin-6 in mortality from and physiologic response to sepsis.

Authors:  Daniel G Remick; Gerald Bolgos; Shannon Copeland; Javed Siddiqui
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  Early elevation in random plasma IL-6 after severe injury is associated with development of organ failure.

Authors:  Joseph Cuschieri; Eileen Bulger; Valerie Schaeffer; Sana Sakr; Avery B Nathens; Laura Hennessy; Joseph Minei; Ernest E Moore; Grant O'Keefe; Jason Sperry; Daniel Remick; Ronald Tompkins; Ronald V Maier
Journal:  Shock       Date:  2010-10       Impact factor: 3.454

5.  Caspase-1 regulates Escherichia coli sepsis and splenic B cell apoptosis independently of interleukin-1beta and interleukin-18.

Authors:  Anasuya Sarkar; Mark W Hall; Matthew Exline; Judy Hart; Nina Knatz; Na Tosha Gatson; Mark D Wewers
Journal:  Am J Respir Crit Care Med       Date:  2006-08-14       Impact factor: 21.405

6.  Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF alpha and nitrite/nitrate in human septic shock.

Authors:  J A Avontuur; T C Stam; M Jongen-Lavrencic; J G van Amsterdam; A M Eggermont; H A Bruining
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

7.  Sepsis Biomarkers.

Authors:  Yachana Kataria; Daniel Remick
Journal:  Methods Mol Biol       Date:  2021

8.  Coagulase-negative Staphylococcus, catheter-related, bloodstream infections and their association with acute phase markers of inflammation in the intensive care unit: An observational study.

Authors:  Oleksa Rewa; John Muscedere; Steve Reynolds; Xuran Jiang; Daren K Heyland
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

9.  Compartmentalisation of cytokines and cytokine inhibitors in ventilator-associated pneumonia.

Authors:  Julian L Millo; Marcus J Schultz; Conrad Williams; Gerrit J Weverling; Timothy Ringrose; Carolyn I Mackinlay; Tom van der Poll; Christopher S Garrard
Journal:  Intensive Care Med       Date:  2003-11-21       Impact factor: 17.440

Review 10.  Is there value in plasma cytokine measurements in patients with severe trauma and sepsis?

Authors:  Lori F Gentile; Alex G Cuenca; Erin L Vanzant; Philip A Efron; Bruce McKinley; Frederick Moore; Lyle L Moldawer
Journal:  Methods       Date:  2013-05-11       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.